{"id":"W2732470776","doi":"10.1093/annonc/mdx302.002","title":"Phase 1b/II study of cancer stemness inhibitor napabucasin in combination with FOLFIRI +/− bevacizumab (bev) in metastatic colorectal cancer (mCRC) patients (pts)","year":2017,"lang":"en","type":"article","venue":"Annals of Oncology","topic":"Bioactive Compounds and Antitumor Agents","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":8,"is_retracted":false,"has_abstract":false,"ca_institutions":"Ottawa Hospital","funders":"","keywords":"Medicine; FOLFIRI; Internal medicine; Cancer; Colorectal cancer; Gastroenterology; Oncology; Combination therapy; Irinotecan","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00069422,0.0002636835,0.0008253245,0.0003040344,0.0002594941,0.00001331103,0.0004403305,0.0002112239,0.0002303911],"category_scores_gemma":[0.00009517964,0.000233542,0.00006987396,0.0002447206,0.0004269137,0.0002754224,0.0001917531,0.0004829367,0.000002420155],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0001674555,"about_ca_system_score_gemma":0.0003341167,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.002851517,"about_ca_topic_score_gemma":0.02481541,"domain_scores_codex":[0.9975243,0.0006649341,0.0007231038,0.000399122,0.0002497495,0.0004387798],"domain_scores_gemma":[0.9979872,0.0002279677,0.0009771141,0.0002337077,0.0004614246,0.0001125835],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.008684257,0.07060647,0.796228,0.0001533842,0.0005725339,0.0001483849,0.005188446,0.0001539555,0.005625756,0.0001019988,0.0008225593,0.1117143],"study_design_scores_gemma":[0.1198175,0.0361947,0.7704946,0.0002443464,0.0003602249,0.000005426789,0.002010352,0.00101778,0.06108721,0.0002077726,0.007981521,0.000578505],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9957766,0.0003271753,0.000001888541,0.0009044649,0.0009300512,0.001243127,0.0001909104,0.000009662818,0.0006161402],"genre_scores_gemma":[0.9989381,0.0003174893,0.000019955,0.0002559632,0.00004698862,0.0003047919,0.00001972179,0.00002276698,0.00007418948],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.1111358,"threshold_uncertainty_score":0.9929792,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.2443052311328311,"score_gpt":0.5327082909976887,"score_spread":0.2884030598648576,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}